NCT05060783Recruiting
Renal Cancer Detection With Liquid Biopsy
Source: ClinicalTrials.gov · Last updated 30 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Glycosaminoglycans (GAGs) were significantly altered in localized as well advanced RCC compared to healthy samples. In addition, GAG scores correlated with progression-free survival and overall survival (OS) in a prospective cohort of patients with metastatic ccRCC and localized RCC. However, it is still unknown whether alterations in plasma and urine GAGs are exquisitely specific to RCC or are shared by other benign lesions in the kidney, such as angiomyolipomas, oncocytomas, or PEComa.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 16 Sept 2021
- Start date
- 1 Jul 2021
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- Zealand University Hospital
- Diseases
- Kidney cancer
- NCT number
- NCT05060783
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Jul 2021 to the primary completion date, 1 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of heparin for concurrent disease in need of blood dilution (e.g. ongoing deep vein thrombosis or lung emboli). Note: use of of heparin for thrombus prophylaxis in conjunction with primary surgery or postoperatively ≤4 weeks will be allowed.
Other
- Non-clear cell Renal cell carcinoma
- RCC with pure sarcomatoid differentiation, also called sarcoma of the kidney
Who the study is looking for
- Patients who underwent CT-scan with suspicion of renal tumor and the scans show no sign of renal cancer.
- For patient with ccRCC or oncocytoma, they should have a histological verified tumor (Biopsy or surgical specimen)
- Sign up information consent
- Can perform protocol procedure
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zealand University Hospital Coordinator of this site? Confirm its status | Roskilde | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.